Molecular Cancer Therapeutics · 2007 · 36 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DesignGastrointestinal PharmacotherapyCancer ChemopreventionColorectal CancerGastrointestinal Cancer PharmacotherapyNon-opioid AnalgesicsOncology PharmacologyPharmacology Of Nitrous OxideAnti-inflammatory ActivityAnti-inflammatory TherapeuticsAntiproliferative AgentsAntiproliferative Drug ActionColorectal Cancer ChemopreventionCyclooxygenase InhibitorsDisulfide LinkersNonsteroidal Anti-inflammatory Drug Chemoprevention
Chemopreventive agents in colorectal cancer possess either antiproliferative or anti-inflammatory actions. Nonsteroidal anti-inflammatory drugs (NSAID) and cyclooxygenase-2 inhibitors have shown promise, but are compromised by side effects. Nitric oxide donor NSAIDs are organic nitrates conjugated via a labile linker to an NSAID, originally designed for use in pain relief, that have shown efficacy in colorectal cancer chemoprevention. The NO chimera, GT-094, is a novel nitrate containing an NSAID and disulfide pharmacophores, a lead compound for the design of agents specifically for colorectal cancer. GT-094 is the first nitrate reported to reduce aberrant crypt foci (by 45%) when administered after carcinogen in the standard azoxymethane rat model of colorectal cancer. Analysis of proximal and distal colon tissue from 8- and 28-week rat/azoxymethane studies showed that GT-094 treatment reduced colon crypt proliferation by 30% to 69%, reduced inducible NO synthase (iNOS) levels by 33% to 67%, reduced poly(ADP-ribose)polymerase-1 expression and cleavage 2- to 4-fold, and elevated levels of p27 in the distal colon 3-fold. Studies in cancer cell cultures recapitulated actions of GT-094: antiproliferative activity and transient G(2)-M phase cell cycle block were measured in Caco-2 cells; apoptotic activity was examined but not observed; anti-inflammatory activity was seen in the inhibition of up-regulation of iNOS and endogenous NO production in lipopolysaccharide (LPS)-induced RAW 264.7 cells. In summary, antiproliferative, anti-inflammatory, and cytoprotective activity observed in vivo and in vitro support GT-094 as a lead compound for the design of NO chimeras for colorectal cancer chemoprevention.
36
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Anne L. Taylor, Susan Ziesche, Clyde W. Yancy et al. · New England Journal of Medicine · 2004 · 1.8K citations
Medicine, Cardiology, Pharmacology +10